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Abstract
Interventions on macrophages/foam cells to redirect intracellular cholesterol towards efflux pathways could become a very
valuable addition to our therapeutic arsenal against atherosclerosis. However, certain manipulations of the cholesteryl ester
cycle, such as the inhibition of ACAT1, an ER-resident enzyme that re-esterifies cholesterol, are not well tolerated. Previously
we showed that targeting perilipin-2 (PLIN2), a major lipid droplet (LD)-associated protein in macrophages, prevents foam
cell formation and protects against atherosclerosis. Here we have assessed the tolerance of PLIN2-deficient bone marrow
derived macrophages (BMM) to several lipid loading conditions similar to the found during atherosclerosis development,
including exposure to modified low-density lipoprotein (mLDL) and 7-ketocholesterol (7-KC), a free cholesterol (FC)
metabolite, in media with or without cholesterol acceptors. BMM isolated from mice that do or do not express PLIN2 were
tested for apoptosis (TUNEL and cleaved caspase-3), ER stress (CHOP induction and XBP-1 splicing), and inflammation (TNF-
a and IL-6 mRNA levels). Like in other cell types, PLIN2 deficiency impairs LD buildup in BMM. However, while most stress
parameters were elevated in macrophages under ACAT inhibition and 7-KC loading, PLIN2 inactivation was well tolerated.
The data support the safety of targeting PLIN2 to prevent foam cell formation and atherosclerosis.
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Introduction
Lipid-laden macrophages or foam cells are fundamental to the
formation and progression of atherosclerosis [1]. They play the
central role of removing the mLDL retained in the arterial intima
and, consequently, need to deal with a large influx of cholesterol.
The lipoprotein-derived cholesterol ester (CE) is hydrolyzed in the
lysosome and FC is released to the cytoplasm. Part of this FC can
be effluxed to extracellular acceptors such as apolipoprotein A1 or
high-density lipoprotein, but a large portion of it is re-esterified
and stored as CE in cytoplasmic LDs [2]. The fate of intracellular
cholesterol may influence the development of atherosclerosis, and
while re-esterification promotes foam cell formation and choles-
terol retention at the arterial wall, efflux facilitates reverse
cholesterol transport. Since cholesterol is effluxed as FC,
conceivably efflux can be enhanced by increasing the intracellular
FC/CE ratio. However, certain interventions aiming to prevent
CE accumulation as a strategy to increase efflux have actually
been detrimental. For example, cholesterol is re-esterified by
acetyl-CoA acetyltransferase1 (ACAT1) [3] and, therefore,
ACAT1 inhibition would be expected to protect against
atherosclerosis. Conversely, most evidence supports that decreas-
ing ACAT1 activity actually promotes atherosclerosis, which has
been attributed to side effects caused by excess of FC trafficking to
the ER membrane, including ER stress, increased synthesis of
proinflammatory cytokines, and macrophage death [4–7]. Hence,
the foam cell’s tolerance to other manipulations of the cholesteryl
ester cycle needs to be carefully evaluated.
LDs consist of a core of neutral lipid, mainly CE and
triglycerides, coated by a monolayer of phospholipids, FC and
proteins [8]. The most important structural proteins associated to
LDs are the members of the PAT family, named after Perilipin,
Adipose differentiation-related protein and Tail-interacting pro-
tein of 47 kDa [9]. In macrophages the main PAT protein is
PLIN2 (also known as ADFP, ADRP or adipophilin before an
unifying nomenclature was adopted) [10]. PLIN2 plays an
important role in lipid trafficking in macrophages. PLIN2
expression increases following lipid loading in several monocytic
cell lines and in primary macrophages [11–15]. In vivo, PLIN2
mRNA is upregulated in carotid endarterectomy specimens and in
atherosclerosis-studded arteries of apoE
2/2 mice compared to
control healthy arteries [12,14]. PLIN2 overexpression in THP-1
macrophages increases lipid accumulation upon incubation with
acetylated (ac) LDL, while PLIN2 downregulation reduces it [14].
Peritoneal macrophages isolated from PLIN2-deficient mice
display less cytoplasmic LDs and decreased CE following
incubation with oxidized (ox) LDL or acLDL and, consistently,
foam cells in lesions of PLIN2 knockout mice contain less LDs
than those of their wild-type (WT) littermates [12]. Data from
cholesterol trafficking experiments support that, by facilitating CE
accumulation in LDs, PLIN2 hinders cholesterol efflux [12,14].
Previously we showed that PLIN2 deficiency protects apoE-
deficient mice against atherosclerosis [12]. Here we have studied
the response of BMM isolated from mice that do or do not express
PLIN2, in terms of apoptosis, ER stress and inflammation, to
multiple culture conditions that mimic the lipid environment in
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33063different stages of atherosclerosis development. While there was
toxicity associated to ACAT1 inhibition and FC loading, the data
support that PLIN2 inactivation is well tolerated by macrophages.
Materials and Methods
Ethics statement
All animal experiments were conducted following a protocol
approved by the Institutional Animal Care and Use Committee at
Albany Medical College (protocol number 901397). All efforts
were made to minimize suffering.
Cell culture and experimental design
BMM isolated from femurs of PLIN2-deficient mice in C57BL/
6J background [16] and age and gender matched WT controls
were cultured in RPMI-1640 media supplemented with 10% heat-
inactivated fetal bovine serum (FBS) and 15% (v/v) L929 cell-
conditioned medium, that served as the source of M-CSF [17]. At
passage three BMM were subcultured into two six-well plates and
remained untreated, or were treated for 20 hours with acLDL
(50 mg/ml; Biomedical Technologies), an ACAT inhibitor
(ACATi; 10 mg/ml; Sandoz 58-035, Sigma-Aldrich), the combi-
nation of acLDL plus ACATi, or 7-KC (50 mM; Sigma-Aldrich).
These concentrations of acLDL combined with ACATi or 7-KC
alone have previously been shown to induce ER-stress and
apoptosis in macrophages [18–21]. Because the 7-KC was
dissolved in ethanol, we also included an ethanol/vehicle group.
To mimic the limited access to extracellular cholesterol acceptors
in the core of advanced lesions, the study was performed in parallel
in media without FBS. The study design is summarized in Table 1.
Nine mice of each genotype were included, and their BMM were
used to obtain protein (n=3), RNA (n=3) or for staining (n=3).
Western blots and quantitative PCRs
Fifteen mg of protein were resolved by SDS-PAGE and
transferred onto a PVDF membrane. The antibodies used for
Western blot included a rabbit anti-PLIN2 (Novus Biologicals), a
rabbit anti-GADD153 [C/EBP-homologous protein (CHOP),
Santa Cruz Biotecnologies], a rabbit anti-cleaved caspase-3 (Cell
Signaling), and a rabbit anti-GAPDH (Sigma-Aldrich). RNA was
isolated with TRIzol (Invitrogen), digested with DNase I and
purified using the Absolutely RNA miniprep kit (Agilent
Technologies). Reverse transcription of 500 ng of total RNA was
performed with SuperScript III (Invitrogen). Primer sequences
were designed with Primer3 software [22] and are available in
Table S1. Quantitative real-time PCR (qPCR) was performed
with SYBR Green QPCR Master Mix from Stratagene (Cedar
Creek, TX) using 40 amplification cycles (95uC for 30 s, 55uC for
1 min, 72uC for 1 min). Relative gene expression levels were
determined from threshold cycle (Ct) values normalized to
cyclophilin A as we previously described [12]. The splicing of
X-box binding protein 1 (XBP-1) was assessed by RT-PCR using
primers that detect both unspliced (205 bp) and spliced (179 bp)
isoforms. PCR products were separated in 6% polyacrylamide gels
and visualized by ethidium bromide staining. Relative protein
levels and XBP-1 mRNA splicing were quantified using ImageJ
software.
Oil red O and TUNEL stainings
For oil red O (ORO) staining BMM were fixed with 3.7%
paraformaldehyde, washed with phosphate buffered saline (PBS)
and stained for 30 minutes with ORO (Sigma-Aldrich; 0.3% w/v
in 60% isopropanol). Nuclei were stained with hematoxylin
(Vector Laboratories). TUNEL staining was performed with the
DeadEnd Fluorometric TUNEL system (Promega), and cell nuclei
were stained with DAPI (Sigma-Aldrich). Cell number and
TUNEL-positive cells in six to ten randomly selected fields per
sample were quantified blindly by two independent investigators.
Data analysis
Statistical significance of the effect of the three independent
variables included in this study (PLIN2 genotype, treatment, and
presence or absence of FBS) was determined by three way
ANOVA using the SigmaStat software. Pairwise comparisons were
performed by the Holm-Sidac method. In addition, a two-tailed
Student’s t-test was used to compare WT and PLIN2-deficient
macrophages within each treatment group. Differences were
considered significant at p,0.05. Results are shown as mean 6
SEM.
Results
Role of PLIN2 in LD formation in BMM
BMM can be expanded in vitro, and this allowed us to obtain
enough cells to simultaneously compare the response between WT
and PLIN2-deficient macrophages under multiple culture condi-
tions. Because the role of PLIN2 on LD formation in BMM had
not been studied, first we asked whether this is similar to the
previously described in other primary macrophages and mono-
cyte/macrophage cell lines [12,14]. As seen in Figure 1A and 1B,
qPCR analysis showed that upon incubation with acLDL there
was a significant (,4-fold) increase in PLIN2 mRNA. At the
protein level, while by immunoblot PLIN2 was barely detectable
in untreated cells, it was ,18-fold higher in acLDL-treated BMM
(Figure 1C and 1D). Note that when not bound to LDs PLIN2 is
rapidly degraded by the proteasome, and very low levels of the
protein are expected in non-lipid laden cells [23]. On the other
hand, as seen in Figure 1E, ORO staining showed abundant
cytoplasmic LDs in acLDL-treated WT BMM, but the absence of
PLIN2 markedly reduced LD buildup. Thus, in agreement with
previous observations in multiple tissues and cell types, including
macrophages, in BMM PLIN2 mRNA and protein are upregu-
lated by lipid loading, and the absence of PLIN2 hinders LD
formation.
PLIN2 inactivation does not induce apoptosis in BMM
Cholesterol loading can induce macrophage apoptosis [7]. If
high rates of apoptosis overpower the efferocytosis (clearance of
Table 1. Experimental design.
Untreated control acLDL (50 mg/ml) ACATi (10 mg/ml) acLDL+ACATi Control (ethanol) 7-KC (50 mM)
+FBS 2FBS +FBS 2FBS +FBS 2FBS +FBS 2FBS +FBS 2FBS +FBS 2FBS
WT KO WT KO WT KO WT KO WT KO WT KO WT KO WT KO WT KO WT KO WT KO WT KO
doi:10.1371/journal.pone.0033063.t001
PLIN2 Deficiency Is Well Tolerated by Foam Cells
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33063apoptotic bodies) capacity of the neighboring macrophages, the
accumulated apoptotic bodies may become disrupted and release
their proatherogenic cargo [24]. In early atherogenesis foam cell
formation is primarily due to mLDL uptake. In advanced lesions
the cells are also exposed to FC and its oxidized derivates, in an
environment relatively poor in cholesterol acceptors. Thus, our
treatments included acLDL, a form of mLDL avidly taken-up by
macrophages, and 7-KC, a FC oxidation product found in
atherosclerotic lesions [25]. Media with or without FBS allowed or
limited access to extracellular acceptors, respectively.
Apoptosis was assessed by two commonly used methods:
TUNEL to detect DNA fragmentation and Western blot to detect
cleaved caspase-3. The TUNEL results are summarized in
Figure 2. Briefly, in macrophages cultured with FBS there was a
low (,1%) rate of apoptosis in the untreated and in the ACATi
and acLDL-treated groups, and was not affected by the PLIN2
genotype. Treatment with acLDL+ACATi increased the rate of
apoptosis to ,2.6% in WT macrophages and to ,5.6% in
PLIN2-deficient macrophages, but the difference between geno-
types did not reach statistical significance. The effect of 7-KC was
Figure 1. PLIN2 is upregulated by lipid loading in BMM, and PLIN2 deficiency inhibits LD accumulation. (A) Representative RT-PCR
analysis (29 cycles) showing PLIN2 mRNA induction by acLDL (50 mg/ml for 20 h) in BMM. (B) qPCR analysis of PLIN2 mRNA expression relative to
cyclophilin A in WT BMM macrophages. n=3, **p,0.01. (C) Representative Western blot and (D) quantification of PLIN2 protein relative to GAPDH in
BMM cultured with or without acLDL. n=3, **p,0.01. (E) Oil red O staining in WT (left) and PLIN2-deficient (right) BMM cultured with acLDL.
doi:10.1371/journal.pone.0033063.g001
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+/+
macrophages and 10.6% in PLIN2
2/2 macrophages. In general,
the rate of apoptosis increased when the macrophages were
cultured without FBS, ranging between 1.5 and 4% in the control,
acLDL and ACATi groups. Again, acLDL treatment did not
induce apoptosis in PLIN2-deficient macrophages and in this case
the rate of apoptosis in acLDL+ACATi-treated cells was similar in
both genotypes (6.1% in PLIN2
+/+ macrophages and 6.0% in
PLIN2
2/2 macrophages). 7-KC treatment also increased the
number of TUNEL positive cells to a comparable level in both
genotypes: 21.7 and 22.4% in WT and PLIN2-deficient
macrophages, respectively. Three way ANOVA analyses showed
that FBS depletion significantly increased apoptosis. Among the
treatments, the effect of 7-KC was highly significant. While
comparisons between the acLDL+ACATi treatment and each one
of the other treatment groups yielded p values,0.05, these values
did not reach the critical level to be considered significant in this
analysis. The PLIN2 genotype did not influence the results
(p=0.650). The ANOVA results are summarized in Table S2. In
addition, t-test analyses did not show significant differences
between WT and PLIN2-deficient macrophages under any
condition.
The levels of the 17 kD subunit of active caspase-3 paralleled
the TUNEL data. As seen in Figure 3A, cleaved caspase-3 was
detectable only in acLDL+ACATi and 7-KC-treated macro-
phages. Treatment with acLDL did not induce caspase-3
activation in PLIN2-deficient cells whether they were cultured
with or without FBS. Interestingly, capase-3 activation was higher
in FBS+/acLDL+ACATi-treated PLIN2
2/2 macrophages than
in their WT counterparts, although this difference was not
statistically significant (Figure 3B). In summary, we only observed
a modest trend of increase in apoptosis markers in PLIN2-
deficient cells when they were cultured with acLDL in the
presence FBS and with the ACAT activity inhibited pharmaco-
logically. Under all other conditions, PLIN2 deficiency did not
increase apoptosis.
PLIN2 inactivation does not increase lipid-induced ER
stress in BMM
TheERis considered the mainsite ofcholesterol-induced toxicity
in foam cells [5,26]. We asked whether PLIN2 deficiency could
induce a subapoptotic level of ER stress that in a multi-hit scenario
could facilitate apoptosis induction by other factors [24]. We
analyzed two parameters commonly used to detect activated
unfolded protein response (UPR), the adaptive response of the ER
to stress: the induction of CHOP and the splicing of XBP-1 [27]. As
seen in Figure 4A, CHOP, a proapoptotic transcription factor
[5,21,28], was robustly induced by 7-KC and to a lesser extend by
mLDL+ACATi, the two conditions that increased apoptosis.
Treatment with acLDL or ACAT inhibitor alone did not cause
CHOP induction in PLIN2-deficient BMM whether they were
cultured with or without FBS, and PLIN2-deficient and WT BMM
responded to 7-KC indistinguishably. Interestingly, compared to
WT BMM CHOP was moderately elevated in PLIN2-deficient
macrophages in the FBS+/acLDL+ACATi group (Figure 4B).
The highest rates of XBP-1splicing were also observed in 7-KC-
treated macrophages cultured both with and without FBS, and in
the FBS2/acLDL+ACATi group. PLIN2 inactivation did not
increase XBP-1 splicing in any treatment group, including the
FBS+/acLDL+ACATi group (Figure 4C and 4D). Thus, both
UPR markers increased under conditions known to induce ER
stress, i.e. 7-KC loading and treatment with acLDL+ACATi in the
absence of FBS [29,30]. However, PLIN2 inactivation did not
alter these markers except for a moderate increase in CHOP
induction in macrophages treated with acLDL+ACATi in the
presence of FBS.
Lack of PLIN2 does not increase the synthesis of TNF-a
and IL-6 in BMM
Inflammation is a major player in atherogenesis [31]. Previous
work has shown that FC accumulation in macrophages can induce
the synthesis of inflammatory cytokines such as tumor necrosis
factor-a (TNF-a) and interleukin-6 (IL-6) [6,32,33]. Thus, we
Figure 2. Analysis of apoptosis: TUNEL staining. (A) Representative images of TUNEL staining in untreated and acLDL, acLDL+ACATi and 7-KC-
treated BMM isolated from WT and PLIN2-deficient mice cultured with or without FBS supplementation. TUNEL positive cells (green) are pointed by
arrows. Bar=50 mm. (B) Quantification of TUNEL positive cells in all the treatment groups (n=3). The results of a three-way ANOVA analysis of these
data are shown in Table S2 online.
doi:10.1371/journal.pone.0033063.g002
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cytokines. As seen in Figure 5, in macrophages cultured in the
presence of FBS 7-KC treatment resulted in ,2.5 and ,30-fold
induction of TNF-a and IL-6 mRNA, respectively. In the
remaining treatment groups the mRNA levels were similar to
those in the control group. FBS deprivation resulted in a variable
induction of both cytokines, but both transcripts were higher in 7-
KC-treated BMM. No significant differences between genotypes
were observed when comparisons within each individual treatment
group were performed by t-test under any experimental condition.
Three-way ANOVA analysis showed that FBS depletion and 7-
KC treatment significantly increased the levels of both transcripts,
while the PLIN2 genotype did not influence the results. The
ANOVA results are summarized in Tables S3 and S4.
Discussion
Arguably, proving the safety of a molecular intervention with
potential therapeutic use is as relevant as proving its efficiency.
Previously we showed that PLIN2 ablation does not affect acLDL
binding and cholesterol uptake by macrophages, but it hampers
the foam cell’s ability to accumulate surplus of cholesterol as CE in
cytoplasmic LDs [12]. Thus, under PLIN2 deficiency part of the
cholesterol that would be stored in LDs will need to be
redistributed within the cell. On one hand this may be beneficial
because some of it may traffic to compartments from where it can
be effluxed, and this is probably why macrophages lacking PLIN2
showed increased cholesterol efflux [12]. However, this may also
cause more FC recirculation to the ER, which inherently implies
more risk of ER stress. In this study we have assessed the tolerance
of PLIN2-deficient macrophages to different forms of lipid
exposure, including milder conditions expected in early athero-
genesis such as exposure to mLDL in the presence of extracellular
cholesterol acceptors, but also two more stressing conditions
expected within advanced lesions, namely exposure to mLDL in
the absence of extracellular acceptors and exposure to free and
oxidized cholesterol derivates. Treatment with an ACAT inhibitor
allowed comparing the effects of PLIN2 deficiency to those of a
well-known inducer of ER stress-mediated apoptosis. Collectively,
our data support that PLIN2 deficiency is well tolerated by the
macrophage. Consistent with observations in macrophages from
other sources, PLIN2 deficiency reduced LD formation in BMM.
However, conversely to what happened under ACAT inhibition,
acLDL treatment did not induce ER stress and did not increase
the rate of apoptosis in PLIN2
2/2 macrophages even when they
were cultured in the absence of FBS, a condition that hampers the
cell’s ability to efflux cholesterol and, consequently, could increase
its dependence on cholesterol storage. In addition, while 7-KC
induced ER stress, apoptosis and inflammation in macrophages
cultured with and without FBS, these effects were similar in
macrophages of both genotypes. A possible explanation for the low
toxicity associated to PLIN2 deficiency compared to ACAT
inhibition may rely on the cellular localization of the proteins. The
ER membrane is extraordinarily poor in cholesterol, and while FC
accumulation at the ER has a marked proapoptotic effect,
macrophages show better tolerance to FC accumulation at the
Figure 3. Analysis of apoptosis: caspase-3 activation. (A) Representative Western blots to detect the 17 kD subunit of active caspase-3. The
band was detectable only in the acLDL+ACATi and 7-KC-treatment groups. (B) Quantification of the 17 kD caspase-3 fragment relative to GAPDH in
the acLDL+ACATi and 7-KC-treatment groups (n=3).
doi:10.1371/journal.pone.0033063.g003
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33063Figure 4. Analysis of ER stress: CHOP induction and XBP-1 splicing. (A) Representative Western blot showing CHOP induction only in the
acLDL+ACATi and 7-KC-treatment groups. The band was detectable only in the acLDL+ACATi and 7-KC-treatment groups. (B) Quantification of CHOP
relative to GAPDH in the acLDL+ACATi and 7-KC-treatment groups (n=3; *p,0.05 respect to WT). (C) XBP-1 unspliced (U) and spliced (S) mRNAs in
the different treatment groups. (D) Quantification of splicing. The bars represent % of spliced XBP-1 with respect to the total (spliced+unspliced) XBP-
1. n=3.
doi:10.1371/journal.pone.0033063.g004
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actually matters when we target the cholesterol ester cycle.
Interestingly, we observed a moderate increase in TUNEL positive
cells, cleaved caspase-3 and CHOP induction in PLIN2-deficient
macrophages treated simultaneously with acLDL and an ACAT
inhibitor in the presence of FBS. The increase in CHOP and
apoptosis markers was limited to this group, and was markedly
lower than the seen after FBS withdrawal. Altogether, these data
suggest that while PLIN2 deficiency may actually increase
cholesterol recirculation through the ER, this does not cause ER
stress unless re-esterification is blocked.
The existence of a cholesterol esterification/hydrolysis cycle in
macrophages has been known for decades [2]. However, there are
still many missing pieces in a puzzle that we need to solve if we
want to tackle cholesterol trafficking to prevent foam cell
formation and atherosclerosis. Previously we showed that targeting
PLIN2 reduces foam cell formation and atherosclerosis [12]. Here
we show that PLIN2 ablation is well tolerated by macrophages.
Overall, the data support the therapeutic potential of interventions
at the LD level aiming to mobilize intracellular cholesterol towards
efflux and reverse transport pathways to slow-down atherogenesis.
Supporting Information
Table S1 Primer sequences.
(DOCX)
Table S2 Three way ANOVA analysis of the TUNEL
data.
(DOCX)
Table S3 Three way ANOVA analysis of the TNF-a
mRNA levels.
(DOCX)
Table S4 Three way ANOVA analysis of the IL-6 mRNA
levels.
(DOCX)
Figure 5. Analysis of inflammation: TNFa and IL-6 mRNA. qPCR analysis of TNF-a (A) and IL-6 (B) mRNA expression relative to cyclophilin A.
(n=3). The results of three-way ANOVA analyses of these data are shown in Tables S3 and S4 in the online data supplement.
doi:10.1371/journal.pone.0033063.g005
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